ARTICLE | Company News
Mundipharma, Shionogi deal
December 9, 2013 8:00 AM UTC
Shionogi gained exclusive, Japanese rights to develop and commercialize Mundipharma's OxyContin Neo oxycodone and Targin oxycodone/naloxone to treat pain. Mundipharma will receive an undisclosed upf...